Rifampin, a useful drug for nonmycobacterial infections.


Rifampin has clinical efficacy against a wide variety of organisms, including Staphylococcus aureus, Legionella pneumophila, group A Streptococcus, Brucella sp, Haemophilus influenzae, and Neisseria meningitidis, as well as in vitro activity against penicillin-resistant Streptococcus pneumoniae, Neisseria gonorrhoeae, Chlamydia trachomatis, Haemophilus ducreyi, and many gram-negative rods. Rifampin is a useful drug for several types of bacterial infections because of its broad spectrum of activity, excellent tissue penetration, and low side effect profile. In combination with other antibiotics, it may be effective when conventional therapies are not.

Cite this paper

@article{Vesely1998RifampinAU, title={Rifampin, a useful drug for nonmycobacterial infections.}, author={J. J. Vesely and Francis D. Pien and Brian C Pien}, journal={Pharmacotherapy}, year={1998}, volume={18 2}, pages={345-57} }